Cite
HARVARD Citation
Roque, D. et al. (2016). Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine Leiomyosarcoma. International journal of gynecological cancer. 26 (3), pp. 505-511. [Online].